Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15695794 | 0.99 | — | — | |
| SCHEMBL15695777 | 0.96 | — | — | |
| SCHEMBL18333932 | 0.95 | CYP1B1 (0.31) | — | |
| SCHEMBL15696187 | 0.94 | CYP1B1 (0.31) | — | |
| SCHEMBL15696150 | 0.93 | CYP1B1 (0.30) | — | |
| SCHEMBL15696189 | 0.93 | CYP1B1 (0.30) | — | |
| SCHEMBL18333854 | 0.92 | — | — | |
| SCHEMBL18333835 | 0.92 | CYP1B1 (0.32) | — | |
| SCHEMBL15696155 | 0.92 | — | — | |
| SCHEMBL18333717 | 0.92 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9985213-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-29 | — | — | US | disclosed |
| US-9985213-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2018-05-29 | — | — | US | disclosed |
| US-20170324039-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-20170324039-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2017-11-09 | — | — | US | disclosed |
| US-9748494-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-29 | — | — | US | disclosed |
| US-9748494-B2 | Compound, material for organic electroluminescence element, organic electroluminescence element, and electronic apparatus | IDEMITSU KOSAN CO., LTD. (JP) | 2017-08-29 | — | — | US | disclosed |
| US-20160372664-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
| US-20160372664-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2016-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160372664-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | RER1, LEF1, RIF1 | ALK 855/4885 |
| US-20170324039-A1 | COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENCE ELEMENT, ORGANIC ELECTROLUMINESCENCE ELEMENT, AND ELECTRONIC APPARATUS | RER1, OR10J3, LEF1 | ALK 833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.